New prosthetic ankle is successfully implanted
The world renowned surgeon from Basel, Beat Hintermann, has successfully implanted ankle prosthesis of his own design in five patients in Liestal. Hintermann products are distributed by the U.S. company DT MedTech LLC.
Beat Hintermann is a world renowned foot and ankle surgeon. He is also a professor at the University of Basel and has developed a range of ankle prosthesis known as the Hintermann Series.
Now, DT MedTech has announced that Hintermann has successfully implanted his new two-component, semi-constrained total ankle prosthesis in five patients in Liestal.
Four of the procedures were total ankle replacements and the fifth was a takedown of a mal-position arthrodesis.
The new development is indicated for painful arthritic ankle joints due to primary osteoarthritis, post-traumatic osteoarthritis, or arthritis secondary to inflammatory disease.
The prosthesis can also be used as a revision for failed ankle replacements or non-union and mal-union of immobile ankle joints.
“I am extremely pleased with the outcomes of the recent H2 surgeries performed, especially as the patients were able to bear their own weight just 24 hours after the devices were implanted,” commented Hintermann in the statement.
Thanks to the new prosthesis, he can expand patient selection for total ankle replacements.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More